U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SEC File Number ___________
CUSIP Number _____________
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D
[ ] Form N-SAR
For Period Ended: June 30, 2010
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 10-Q
For the Transition Period Ended: ________________________________
- ---------------------------------
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
- ---------------------------------
Part I - Registrant Information
- ---------------------------------
Full Name of Registrant: EFT BIOTECH HOLDINGS, INC.
Former Name if Applicable: N/A
Address of Principal Executive Office (Street and Number)
17800 Castleton St., Suite 300
City, State and Zip Code
City of Industry, CA 91748
1
- ---------------------------------
Part II - Rules 12b-25(b) and (c)
- ---------------------------------
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
(Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, or transition report
or portion thereof will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly report
or transition report on Form l0-Q or portion thereof will be filed on
or before the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
- ---------------------------------
Part III - Narrative
- ---------------------------------
State below in reasonable detail the reasons why the Form 10-K, 20-F,
11-K, 10-Q, or N-SAR, or the transition report or portion thereof could not be
filed within the prescribed time period.
The Company did not complete its financial statements for the three months
ended dateYear2010Day30Month6lstransJune 30, 2010 in sufficient time so as to
allow the filing of the report by dateYear2010Day9Month8lstransAugust 9, 2010.
- ---------------------------------
Part IV - Other Information
- ---------------------------------
(1) Name and telephone number of person to contact in regard to this
notification
William T. Hart (303) 839-0061
----------------- ----- --------
(Name) (Area Code) (Telephone Number)
2
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding l2 months (or
for such shorter period that the registrant was required to file such
reports) been filed? If answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? [X] Yes [ ] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Net income for the three months ended June 30, 2010 was $648,250 as
opposed to a loss of $(407,924) for the three months ended June 30,
2009.
EFT BIOTECH HOLDINGS, INC.
----------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: August 10, 2010 By /s/ William T. Hart
--------------------
William T. Hart
Hart & Trinen, LLP
1624 Washington St.
Denver, CO 80203
(303) 839-0061
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).